What is Siriuspoint Ltd's earnings per share (EPS)?

Siriuspoint Ltd (SPNT) reported diluted earnings per share of $3.64 for fiscal year 2025. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Siriuspoint Ltd Financials

SPNT

FY2025 annual

Revenue $3.2B +23.1% YoY

Net Income $460.0M +130.0% YoY

EPS (Diluted) $3.64 YoY not available

Free Cash Flow Not reported for FY2025

Source SEC Filings (10-K/10-Q) Data as of Jun 30, 2026 Currency USD FYE December

Siriuspoint Ltd (SPNT) reported $3.2B in revenue for fiscal year 2025, up 23.1% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI SPNT FY2025 2026-07-29

Reported profit surged in FY2025, but the dominant mechanic remains a balance-sheet-heavy model with thin cash conversion.

Net income swung from -$387M at the trough to $460M at the latest year, a full-cycle repair in reported profitability. But operating cash flow fell from $581.3M to $102.4M over the same span, so the earnings rebound relied more on balance-sheet and accounting outcomes than on cash arriving at the same pace.

The latest year's $490.8M of share buybacks exceeded $460M of net income, so capital return drew on accumulated balance-sheet capacity rather than current-year cash generation alone. That was possible because long-term debt stayed under $700M while equity rebuilt to nearly $2.5B, leaving room to repurchase shares without leaning harder on leverage.

With $3.2B of revenue supported by roughly $12.6B of assets, this is a balance-sheet-heavy business where earnings can move sharply even when sales do not. ROA of 3.7% still translated into ROE of 18.6%, which shows shareholder returns are being amplified by the liability structure rather than by a simple high-margin operating model.

Financial Health Signals

Financial Health Score 33/100

Scored as: Insurers peer group

Scored against insurers for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Siriuspoint Ltd's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Loss Ratio

Premium Growth

Capital

Investment Yield

Not available for Siriuspoint Ltd, and counted as zero in the overall score.

Combined Ratio

Stability

Piotroski F-Score Partial

4/7

Siriuspoint Ltd passes 4 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 3 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), both operating efficiency signals pass.

Earnings Quality Low Quality

0.22x

For every $1 of reported earnings, Siriuspoint Ltd generates $0.22 in operating cash flow ($102.4M OCF vs $460.0M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$3.2B

YoY+23.1%

5Y CAGR+29.2%

10Y CAGR+18.8%

Siriuspoint Ltd generated $3.2B in revenue in fiscal year 2025. This represents an increase of 23.1% from the prior year.

Net Income

$460.0M

YoY+130.0%

5Y CAGR+26.2%

Siriuspoint Ltd reported $460.0M in net income in fiscal year 2025. This represents an increase of 130.0% from the prior year.

EPS (Diluted)

$3.64

Siriuspoint Ltd earned $3.64 per diluted share (EPS) in fiscal year 2025.

EBITDA

Not reported for fiscal year 2025.

Cash & Balance Sheet

Cash & Debt

$731.2M

YoY+7.2%

5Y CAGR+6.8%

10Y CAGR+43.0%

Siriuspoint Ltd held $731.2M in cash against $688.6M in long-term debt as of fiscal year 2025.

Shares Outstanding

117M

Siriuspoint Ltd had 117M shares outstanding in fiscal year 2025.

Free Cash Flow

Not reported for fiscal year 2025.

Dividends Per Share

Not reported for fiscal year 2025.

Margins & Returns

Net Margin

14.3%

YoY+6.7pp

5Y CAGR-1.8pp

10Y CAGR+29.5pp

Siriuspoint Ltd's net profit margin was 14.3% in fiscal year 2025, showing the share of revenue converted to profit. This is up 6.7 percentage points from the prior year.

Return on Equity

18.6%

YoY+8.3pp

5Y CAGR+9.4pp

10Y CAGR+24.9pp

Siriuspoint Ltd's ROE was 18.6% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 8.3 percentage points from the prior year.

Gross Margin

Not reported for fiscal year 2025.

Operating Margin

Not reported for fiscal year 2025.

Capital Allocation

Share Buybacks

$490.8M

YoY+63.8%

Siriuspoint Ltd spent $490.8M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents an increase of 63.8% from the prior year.

R&D Spending

Not reported for fiscal year 2025.

Capital Expenditures

Not reported for fiscal year 2025.

SPNT Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

SPNT annual income statement

Metric	TTM	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11
Revenue	$3.2B	$3.2B+23.1%	$2.6B-4.9%	$2.7B+30.0%	$2.1B-3.4%	$2.2B+145.1%	$889.7M-9.5%	$982.6M+165.6%	$370.0M-60.6%	$939.0M+36.3%	$689.0M+19.9%	$574.8M+8.4%	$530.1M+10.7%	$478.8M+105.2%	$233.3M	$0
SG&A Expenses	N/A	N/A	N/A	N/A	N/A	N/A	$61.4M+14.3%	$53.8M+48.3%	$36.2M-31.8%	$53.1M+34.9%	$39.4M-14.5%	$46.0M+15.1%	$40.0M+21.1%	$33.0M+20.7%	$27.4M+2322.7%	$1.1M
Interest Expense	$76.0M	$79.7M+14.5%	$69.6M+8.6%	$64.1M+66.1%	$38.6M+13.5%	$34.0M+314.6%	$8.2M0.0%	$8.2M-0.3%	$8.2M0.0%	$8.2M-0.1%	$8.2M+13.8%	$7.2M	$0	$0	N/A	N/A
Income Tax	$91.3M	$81.2M+164.5%	$30.7M+168.2%	-$45.0M-22.6%	-$36.7M-243.0%	-$10.7M-232.1%	$8.1M+1057.1%	$700K+117.5%	-$4.0M-133.5%	$12.0M+114.1%	$5.6M+292.5%	-$2.9M-151.4%	$5.6M	$0	$0	N/A
Net Income	$506.0M	$460.0M+130.0%	$200.0M-43.7%	$355.0M+191.7%	-$387.0M-767.2%	$58.0M-59.6%	$143.5M-28.5%	$200.6M+163.1%	-$317.7M-214.4%	$277.8M+905.2%	$27.6M+131.6%	-$87.4M-273.4%	$50.4M-77.8%	$227.3M+128.7%	$99.4M+8896.5%	-$1.1M
EPS (Diluted)	—	$3.64	$1.04-43.8%	$1.85+173.7%	-$2.51-1029.6%	$0.27	$1.53-29.2%	$2.16+166.1%	-$3.27-223.9%	$2.64+915.4%	$0.26+131.0%	-$0.84-278.7%	$0.47-81.5%	$2.54+101.6%	$1.26	N/A

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Revenue	$744.1M-3.9%	$774.6M-20.4%	$973.7M+28.8%	$755.9M+1.0%	$748.2M+2.9%	$727.3M+18.7%	$612.8M+9.0%	$562.2M
Interest Expense	$18.7M+11.3%	$16.8M-13.8%	$19.5M-7.1%	$21.0M-0.5%	$21.1M+16.6%	$18.1M-7.7%	$19.6M+42.0%	$13.8M
Income Tax	$15.8M-17.7%	$19.2M-46.8%	$36.1M+78.7%	$20.2M+74.1%	$11.6M-12.8%	$13.3M+202.3%	$4.4M+83.3%	$2.4M
Net Income	$68.6M-32.9%	$102.2M-58.2%	$244.4M+169.2%	$90.8M+43.7%	$63.2M+2.6%	$61.6M+458.1%	-$17.2M-302.4%	$8.5M
EPS (Diluted)	$0.58-29.3%	$0.82	N/A	$0.73+46.0%	$0.50+2.0%	$0.49	N/A	$0.03

Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses, Operating Income.

TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.

SPNT Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

SPNT annual balance sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11
Total Assets	$12.6B+0.4%	$12.5B-2.7%	$12.9B+16.6%	$11.0B+3.9%	$10.6B+200.4%	$3.5B+8.9%	$3.2B+5.2%	$3.1B-33.9%	$4.7B+19.9%	$3.9B+9.9%	$3.5B+24.3%	$2.9B+32.1%	$2.2B+54.1%	$1.4B	N/A
Cash & Equivalents	$731.2M+7.2%	$682.0M-29.6%	$969.2M+37.4%	$705.3M-29.5%	$999.8M+90.1%	$526.0M-17.7%	$639.4M+513.7%	$104.2M+1171.0%	$8.2M-17.6%	$10.0M-51.2%	$20.4M-29.0%	$28.7M-9.1%	$31.6M-7.0%	$34.0M-94.4%	$603.8M
Accounts Receivable	N/A	N/A	N/A	N/A	$14.5M	$0	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	$0	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$10.1B-4.6%	$10.6B+2.4%	$10.3B+15.5%	$9.0B+10.3%	$8.1B+311.9%	$2.0B+7.6%	$1.8B-2.7%	$1.9B-35.2%	$2.9B+18.6%	$2.4B+13.8%	$2.1B+65.3%	$1.3B+100.2%	$649.5M+37.1%	$473.7M	N/A
Long-Term Debt	$688.6M+7.7%	$639.1M-18.7%	$786.2M+1.1%	$778.0M-4.7%	$816.7M+614.5%	$114.3M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$2.5B+27.5%	$1.9B-22.9%	$2.5B+21.2%	$2.1B-17.1%	$2.5B+60.1%	$1.6B+10.6%	$1.4B+17.4%	$1.2B-27.3%	$1.7B+17.1%	$1.4B+2.5%	$1.4B-5.0%	$1.5B-3.9%	$1.5B+62.7%	$928.3M+58.6%	$585.4M
Retained Earnings	$1.2B+56.5%	$784.9M+30.6%	$601.0M+129.2%	$262.2M-60.6%	$665.0M+7.2%	$620.4M+30.1%	$476.9M+72.6%	$276.3M-53.5%	$594.0M+87.8%	$316.2M+9.6%	$288.6M-23.2%	$376.0M+15.5%	$325.6M+231.3%	$98.3M	N/A

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Total Assets	$12.7B+1.4%	$12.5B-0.7%	$12.6B+0.9%	$12.5B+0.8%	$12.4B+0.6%	$12.3B-2.0%	$12.5B-1.2%	$12.7B
Cash & Equivalents	$614.8M-28.3%	$856.9M+17.2%	$731.2M+25.5%	$582.4M-20.5%	$732.4M-1.1%	$740.3M+8.5%	$682.0M+6.4%	$640.7M
Goodwill	$18.6M0.0%	$18.6M	$0	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$10.4B+1.9%	$10.2B+0.8%	$10.1B-1.5%	$10.2B0.0%	$10.2B0.0%	$10.3B-3.1%	$10.6B+6.0%	$10.0B
Long-Term Debt	$675.5M-0.6%	$679.6M-1.3%	$688.6M+0.9%	$682.5M+0.6%	$678.4M+2.2%	$663.5M+3.8%	$639.1M-3.2%	$660.5M
Total Equity	$2.3B-1.2%	$2.3B-6.8%	$2.5B+11.8%	$2.2B+4.9%	$2.1B+4.0%	$2.0B+4.5%	$1.9B-28.1%	$2.7B
Retained Earnings	$1.4B+5.2%	$1.3B+8.1%	$1.2B+24.3%	$988.5M+9.6%	$901.7M+7.0%	$842.5M+7.3%	$784.9M-2.6%	$806.2M

Not reported in any period shown, so not listed: Current Assets, Inventory, Current Liabilities.

SPNT Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

SPNT annual cash flow statement

Metric	TTM	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11
Operating Cash Flow	$265.9M	$102.4M+37.1%	$74.7M-87.1%	$581.3M+98.2%	$293.3M+18231.3%	$1.6M-97.8%	$73.3M-48.1%	$141.1M+954.0%	$13.4M+117.0%	-$78.5M-1746.1%	$4.8M-97.5%	$187.8M+53.4%	$122.4M+521.2%	$19.7M+163.8%	-$30.9M-1886.6%	-$1.6M
Investing Cash Flow	-$144.0M	$424.2M+23.5%	$343.6M+203.4%	-$332.2M+74.5%	-$1.3B-725.3%	$208.6M+3376.7%	$6.0M-99.2%	$786.9M+108.4%	$377.6M+42.3%	$265.2M+411.1%	-$85.3M+48.0%	-$163.9M-37.7%	-$119.1M+72.1%	-$427.1M+47.0%	-$806.1M	$0
Financing Cash Flow	-$299.2M	-$518.8M+17.0%	-$625.0M-916.3%	-$61.5M-159.5%	-$23.7M-197.5%	$24.3M+225.3%	-$19.4M-254.0%	$12.6M+105.6%	-$226.9M-522.3%	$53.7M+41.2%	$38.1M+218.1%	-$32.2M-414.0%	-$6.3M-101.5%	$405.1M+51.6%	$267.2M-55.9%	$605.4M
Dividends Paid	$4.0M	$0	$0	$0	$0	$0	$0	$0	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	$73.3M	$490.8M+63.8%	$299.7M	$0-100.0%	$5.0M	$0	$0	$0-100.0%	$138.7M+239.1%	$40.9M+452.7%	$7.4M	N/A	N/A	N/A	N/A	N/A

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Operating Cash Flow	-$5.2M-103.7%	$141.9M+637.5%	-$26.4M-117.0%	$155.6M+150.6%	$62.1M+169.9%	-$88.9M-182.5%	$107.7M+85.4%	$58.1M
Investing Cash Flow	-$191.4M-201.3%	$189.0M-0.2%	$189.3M+157.2%	-$330.9M-633.7%	-$45.1M-107.4%	$610.9M+200.6%	$203.2M+0.5%	$202.1M
Financing Cash Flow	-$68.2M+69.4%	-$222.6M-12266.7%	-$1.8M+72.7%	-$6.6M+65.3%	-$19.0M+96.1%	-$491.4M-112.3%	-$231.5M-37.0%	-$169.0M
Dividends Paid	$0	$0	$0-100.0%	$4.0M0.0%	$4.0M	$0	$0-100.0%	$4.0M
Share Buybacks	$51.4M+134.7%	$21.9M	$0	$0	$0-100.0%	$490.8M+188.7%	$170.0M+31.1%	$129.7M

Not reported in any period shown, so not listed: Capital Expenditures, Free Cash Flow.

SPNT Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples.

SPNT annual financial ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11
Net Margin	14.3%+6.7pp	7.7%-5.3pp	13.0%+31.4pp	-18.4%-21.0pp	2.7%-13.5pp	16.1%-4.3pp	20.4%+106.3pp	-85.9%-115.4pp	29.6%+25.6pp	4.0%+19.2pp	-15.2%-24.7pp	9.5%-38.0pp	47.5%+4.9pp	42.6%	N/A
Return on Equity	18.6%+8.3pp	10.3%-3.8pp	14.1%+32.8pp	-18.6%-21.0pp	2.3%-6.9pp	9.2%-5.0pp	14.2%+40.6pp	-26.4%-43.1pp	16.8%+14.8pp	1.9%+8.3pp	-6.3%-9.8pp	3.5%-11.6pp	15.0%+4.3pp	10.7%+10.9pp	-0.2%
Return on Assets	3.7%+2.1pp	1.6%-1.2pp	2.8%+6.3pp	-3.5%-4.1pp	0.5%-3.5pp	4.1%-2.1pp	6.2%+16.5pp	-10.3%-16.2pp	5.9%+5.2pp	0.7%+3.2pp	-2.5%-4.2pp	1.8%-8.8pp	10.5%+3.4pp	7.1%	N/A
Debt-to-Equity	0.28-0.1x	0.330.0x	0.31-0.1x	0.380.0x	0.33+0.3x	0.07-1.2x	1.30-0.3x	1.56-0.2x	1.750.0x	1.73+0.2x	1.56+0.7x	0.90+0.5x	0.43-0.1x	0.51	N/A

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Net Margin	9.2%-4.0pp	13.2%-11.9pp	25.1%+13.1pp	12.0%+3.6pp	8.5%0.0pp	8.5%+11.3pp	-2.8%-4.3pp	1.5%
Return on Equity	3.0%-1.4pp	4.4%-5.5pp	9.9%+5.8pp	4.1%+1.1pp	3.0%0.0pp	3.0%+3.9pp	-0.9%-1.2pp	0.3%
Return on Assets	0.5%-0.3pp	0.8%-1.1pp	1.9%+1.2pp	0.7%+0.2pp	0.5%0.0pp	0.5%+0.6pp	-0.1%-0.2pp	0.1%
Debt-to-Equity	0.300.0x	0.300.0x	0.280.0x	0.310.0x	0.320.0x	0.330.0x	0.33+0.1x	0.25

Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Current Ratio, FCF Margin.

Similar Companies

Hamilton Insurance Group HG

$3.4B

Everest Re Gp EG

$14.2B

Renaissance RNR

$13.4B

Reinsurance Grp RGA

$15.9B

Greenlight Capital Re Ltd GLRE

$499.1M

Where Siriuspoint Ltd Ranks

Frequently Asked Questions

What is Siriuspoint Ltd's annual revenue?

Siriuspoint Ltd (SPNT) reported $3.2B in total revenue for fiscal year 2025. This represents a 23.1% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Siriuspoint Ltd's revenue growing?

Siriuspoint Ltd (SPNT) revenue grew by 23.1% year-over-year, from $2.6B to $3.2B in fiscal year 2025.

Is Siriuspoint Ltd profitable?

Yes, Siriuspoint Ltd (SPNT) reported a net income of $460.0M in fiscal year 2025, with a net profit margin of 14.3%.

How much debt does Siriuspoint Ltd have?

As of fiscal year 2025, Siriuspoint Ltd (SPNT) had $731.2M in cash and equivalents against $688.6M in long-term debt.

What is Siriuspoint Ltd's net profit margin?

Siriuspoint Ltd (SPNT) had a net profit margin of 14.3% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is Siriuspoint Ltd's return on equity (ROE)?

Siriuspoint Ltd (SPNT) has a return on equity of 18.6% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Siriuspoint Ltd's operating cash flow?

Siriuspoint Ltd (SPNT) generated $102.4M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Siriuspoint Ltd's total assets?

Siriuspoint Ltd (SPNT) had $12.6B in total assets as of fiscal year 2025, including both current and long-term assets.

Does Siriuspoint Ltd buy back shares?

Yes, Siriuspoint Ltd (SPNT) spent $490.8M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does Siriuspoint Ltd have outstanding?

Siriuspoint Ltd (SPNT) had 117M shares outstanding as of fiscal year 2025.

What is Siriuspoint Ltd's debt-to-equity ratio?

Siriuspoint Ltd (SPNT) had a debt-to-equity ratio of 0.28 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Siriuspoint Ltd's return on assets (ROA)?

Siriuspoint Ltd (SPNT) had a return on assets of 3.7% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Siriuspoint Ltd's Piotroski F-Score?

Siriuspoint Ltd (SPNT) has a Piotroski F-Score of 4 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Siriuspoint Ltd's earnings high quality?

Siriuspoint Ltd (SPNT) has an earnings quality ratio of 0.22x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is Siriuspoint Ltd?

Siriuspoint Ltd (SPNT) scores 33 out of 100 on our Financial Health Score, indicating weak standing within its insurers peer group. The score is a 0-100 composite of six dimensions (Loss Ratio, Premium Growth, Capital, Investment Yield, Combined Ratio, Stability), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.